PPARG and type 2 diabetes mellitus: In a mouse model mechanistic study, miR-222-3p also mediated the therapeutic effects pioglitazone, an oral hypoglycemic drug used for T2D, on skeletal muscle tissue, independent of the PPARγ mechanism-of-action of the drug (66).